The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Tougher sentences will be handed out to perpetrators of domestic violence against children under plans being set out by the Conservatives.
Two people have been arrested after a car crashed into pedestrians in Marbella.
A missile launched by North Korea has landed in the Sea of Japan, according to the Japanese Government.